目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 45)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 MARKET SEGMENTATION
FIGURE 2 MARKET: REGIONAL SEGMENTATION
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 51)
2.1 RESEARCH DATA
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 4 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 8 SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: FLEX, LTD.
FIGURE 10 SUPPLY SIDE ANALYSIS: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET (2021)
FIGURE 11 DEMAND SIDE ESTIMATION FOR MEDICAL DEVICE CONTRACT MANUFACTURING MARKET
FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022-2027)
FIGURE 13 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
2.2.1 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 14 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 STUDY ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.6.2 SCOPE-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET
2.8 IMPACT OF RECESSION ON MEDICAL DEVICE CONTRACT MANUFACTURING MARKET

3 EXECUTIVE SUMMARY (Page No. - 67)
FIGURE 15 MARKET, BY DEVICE, 2022 VS. 2027 (USD MILLION)
FIGURE 16 MARKET, BY CLASS OF DEVICE, 2022 VS. 2027 (USD MILLION)
FIGURE 17 MARKET, BY SERVICE, 2022 VS. 2027 (USD MILLION)
FIGURE 18 GEOGRAPHICAL SNAPSHOT OF MARKET

4 PREMIUM INSIGHTS (Page No. - 70)
4.1 MARKET OVERVIEW
FIGURE 19 TECHNOLOGICAL ADVANCEMENTS IN MEDICAL DEVICE MODALITIES TO DRIVE MARKET
4.2 MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 20 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.3 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.4 MARKET: REGIONAL MIX
FIGURE 22 ASIA PACIFIC TO DOMINATE MARKET IN 2027

5 MARKET OVERVIEW (Page No. - 72)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 23 MARKET DYNAMICS: MARKET
TABLE 3 MARKET DYNAMICS: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Growth in medical devices market in developing countries
FIGURE 24 GDP GROWTH FORECAST: COMPARISON AMONG INDIA, CHINA, US, AND GERMANY, 2020 VS. 2040 (FORECAST)
5.2.1.2 Adoption of robotics and automation in manufacturing processes
5.2.1.3 Technological advancements in medical device modalities
FIGURE 25 FACTORS DRIVING DEMAND FOR CONTRACT MANUFACTURING
5.2.1.4 Impact of industry 4.0 on medical device industry
TABLE 4 DEFINITIONS OF CRITICAL ELEMENTS IN INDUSTRY 4.0 SYSTEM
5.2.2 RESTRAINTS
5.2.2.1 Consolidation in medical devices market by acquiring small and medium-sized companies
TABLE 5 KEY ACQUISITIONS IN MEDICAL DEVICE INDUSTRY (2019-2022)
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing healthcare expenditure, infrastructure, and awareness in developing countries
TABLE 6 HEALTHCARE EXPENDITURE (%), BY COUNTRY (2010 TO 2021)
FIGURE 26 ASIA PACIFIC: HEALTHCARE EXPENDITURE PER CAPITA (USD) (2002 TO 2019)
5.2.3.2 Rising geriatric population and its associated diseases
TABLE 7 ESTIMATED INCREASE IN GERIATRIC POPULATION, BY REGION, 2019 VS. 2050
TABLE 8 AVERAGE LIFE EXPECTANCY, 2023 (FORECAST)
5.2.4 CHALLENGES
5.2.4.1 Lack of constant innovation to balance technological capabilities against costs
5.3 PORTER’S FIVE FORCES ANALYSIS
FIGURE 27 PORTER’S FIVE FORCES ANALYSIS (2020): MARKET
TABLE 9 MARKET: PORTER’S FIVE FORCES ANALYSIS
5.3.1 THREAT OF NEW ENTRANTS
5.3.1.1 Growth in overall medical device industry
5.3.1.2 Demand for compact, cost-effective, and non-invasive devices
5.3.1.3 Consolidation
5.3.1.4 Poor financing environment
5.3.1.5 Stringent regulatory environment
5.3.2 THREAT OF SUBSTITUTES
5.3.2.1 Undesirability of existing portfolios
5.3.2.2 Combination and integration of multiple technologies
5.3.2.3 Availability of alternatives
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.3.1 Big medical device contract manufacturing companies
5.3.3.2 Institutional technology providers
5.3.3.3 Innovative technologies
5.3.3.4 Dysfunctional companies
5.3.3.5 Academic inventors
5.3.4 BARGAINING POWER OF BUYERS
5.3.4.1 Few buyers and many sellers
5.3.4.2 Buy out threat
5.3.4.3 Demand for new pipeline services
5.3.4.4 Point of differentiation
5.3.5 INTENSITY OF COMPETITIVE RIVALRY
5.3.5.1 Similar spectrum of services offered
5.3.5.2 Similar funding source
5.3.5.3 Self-funded big contract manufacturers
5.3.5.4 Highly fragmented industry
5.4 TARIFF AND REGULATORY LANDSCAPE
5.4.1 REGULATORY ANALYSIS
5.4.1.1 North America
5.4.1.1.1 US
TABLE 10 US: CLASSIFICATION OF MEDICAL EQUIPMENT
TABLE 11 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.1.1.2 Canada
TABLE 12 CANADA: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.1.2 Europe
TABLE 13 EUROPE: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.1.3 Asia Pacific
5.4.1.3.1 Japan
TABLE 14 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.1.3.2 China
TABLE 15 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.1.3.3 India
5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.5 KEY CONFERENCES AND EVENTS IN 2022-2023
TABLE 21 DETAILED LIST OF CONFERENCES AND EVENTS
5.6 PATENT ANALYSIS
5.6.1 PATENT PUBLICATION TRENDS FOR MEDICAL DEVICES
FIGURE 28 PATENT PUBLICATION TRENDS (JANUARY 2012-NOVEMBER 2022)
5.6.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 29 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR MEDICAL DEVICES PATENTS (JANUARY 2012-NOVEMBER 2022)
FIGURE 30 TOP 10 APPLICANT COUNTRIES/REGIONS FOR MEDICAL DEVICES PATENTS (JANUARY 2012-NOVEMBER 2022)
TABLE 22 MEDICAL DEVICES: LIST OF MAJOR PATENTS
5.7 TECHNOLOGY ANALYSIS
5.7.1 KEY TECHNOLOGIES
5.7.1.1 Digital Transformation
5.7.1.2 Robotics and Automation
5.7.2 ADJACENT TECHNOLOGIES
5.7.2.1 Artificial Intelligence
5.7.2.2 Big Data
5.7.3 COMPLEMENTARY TECHNOLOGIES
5.7.3.1 5G
5.8 SUPPLY CHAIN ANALYSIS
FIGURE 31 MARKET: SUPPLY CHAIN (2020)
5.9 ECOSYSTEM ANALYSIS
FIGURE 32 MARKET: ECOSYSTEM ANALYSIS (2020)
5.10 TRADE ANALYSIS
TABLE 23 IMPORT VALUE OF MEDICAL DEVICES FOR TOP 10 COUNTRIES IN 2021
TABLE 24 EXPORT VALUE OF MEDICAL DEVICES FOR TOP 10 COUNTRIES IN 2021
5.11 YC-YCC ANALYSIS
FIGURE 33 YC-YCC SHIFT IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL DEVICES
TABLE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL DEVICES
5.12.2 BUYING CRITERIA
FIGURE 35 KEY BUYING CRITERIA FOR MEDICAL DEVICES
TABLE 26 KEY BUYING CRITERIA FOR MEDICAL DEVICES
5.13 ADJACENT MARKETS FOR MEDICAL DEVICE CONTRACT MANUFACTURING
FIGURE 36 ADJACENT MARKETS FOR MEDICAL DEVICE CONTRACT MANUFACTURING
5.14 INDUSTRY TRENDS
5.14.1 INCREASING CONSOLIDATION OF ORIGINAL EQUIPMENT MANUFACTURERS AND CONTRACT MANUFACTURING ORGANIZATIONS
TABLE 27 KEY EXAMPLES OF OEM CONSOLIDATION IN LAST 5 YEARS
TABLE 28 KEY EXAMPLES OF CMO CONSOLIDATION
5.14.2 GROWING INTEREST OF PRIVATE EQUITY FIRMS IN MEDICAL DEVICE CONTRACT MANUFACTURING
TABLE 29 KEY INVESTMENTS BY PRIVATE EQUITY FIRMS
5.14.3 OUTSOURCING OF MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES
TABLE 30 EXAMPLES OF KEY COLLABORATIONS AND AGREEMENTS
5.14.4 INDUSTRY 5.0
5.15 IMPACT OF RECESSION ON MEDICAL DEVICE CONTRACT MANUFACTURING MARKET

6 MARKET, BY DEVICE (Page No. - 110)
6.1 INTRODUCTION
TABLE 31 MARKET, BY DEVICE, 2020-2027 (USD MILLION)
6.2 IVD DEVICES
TABLE 32 MARKET FOR IVD DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 33 MARKET FOR IVD DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.2.1 IVD CONSUMABLES
6.2.1.1 Increasing demand for reagents & kits and focus on COVID-19 screening to drive market
TABLE 34 IVD CONSUMABLES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.2.2 IVD EQUIPMENT
6.2.2.1 Advances in life sciences research to support market
TABLE 35 IVD EQUIPMENT MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.3 DIAGNOSTIC IMAGING DEVICES
6.3.1 ADOPTION OF NEW AND ADVANCED DIAGNOSTIC IMAGING SYSTEMS IN DEVELOPING COUNTRIES TO AUGMENT MARKET
TABLE 36 MARKET FOR DIAGNOSTIC IMAGING DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.4 CARDIOVASCULAR DEVICES
6.4.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO PROPEL MARKET
TABLE 37 PREVALENCE OF CARDIOVASCULAR DISEASES, 2015-2035
TABLE 38 MARKET FOR CARDIOVASCULAR DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.5 DRUG DELIVERY DEVICES
TABLE 39 MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 40 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.5.1 INFUSION DEVICES AND ADMINISTRATION SETS
6.5.1.1 Rising incidence of chronic diseases and number of surgical procedures to fuel market
TABLE 41 INFUSION DEVICES AND ADMINISTRATION SETS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.5.2 SYRINGES
6.5.2.1 High cost of safety syringes and increasing incidence of needlestick injuries to hinder market
TABLE 42 SYRINGES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.5.3 INHALERS
6.5.3.1 High prevalence of asthma, COPD, and cystic fibrosis to aid market
TABLE 43 INHALERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.5.4 AUTOINJECTORS AND PEN INJECTORS
6.5.4.1 Rising number of regulatory approvals for new drug therapies and advancements to support market
TABLE 44 RECENT APPROVALS FOR AUTOINJECTORS AND PEN INJECTORS GLOBALLY (2019-2022)
TABLE 45 AUTOINJECTORS AND PEN INJECTORS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.6 ORTHOPEDIC DEVICES
6.6.1 HIGH PREVALENCE OF ORTHOPEDIC CONDITIONS TO DRIVE MARKET
TABLE 46 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR ORTHOPEDIC DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.7 RESPIRATORY CARE DEVICES
6.7.1 COVID-19 TO BOOST DEMAND FOR CONTRACT MANUFACTURING OF RESPIRATORY CARE DEVICES
TABLE 47 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR RESPIRATORY CARE DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.8 OPHTHALMOLOGY DEVICES
6.8.1 INCREASING PREVALENCE OF OPHTHALMIC DISEASES TO DRIVE MARKET
TABLE 48 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR OPHTHALMOLOGY DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.9 SURGICAL DEVICES
6.9.1 INCREASE IN SURGICAL PROCEDURES TO FUEL MARKET
TABLE 49 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR SURGICAL DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.1 DIABETES CARE DEVICES
6.10.1 RISING PREVALENCE OF DIABETES TO PROPEL MARKET
TABLE 50 TOP FIVE COUNTRIES WITH HIGHEST NUMBER OF DIABETICS (20-79 YEARS) (2021 VS. 2045)
TABLE 51 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DIABETES CARE DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.11 DENTAL DEVICES
6.11.1 RISING INCIDENCE OF DENTAL DISEASES TO DRIVE MARKET
TABLE 52 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DENTAL DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.12 ENDOSCOPY AND LAPAROSCOPY DEVICES
6.12.1 RISING PATIENT PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO AUGMENT MARKET
TABLE 53 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR ENDOSCOPY AND LAPAROSCOPY DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.13 GYNECOLOGY AND UROLOGY DEVICES
6.13.1 GROWING AWARENESS AND PREVENTIVE CHECK-UPS FOR LATE-PHASE DIAGNOSIS OF STDS TO PROPEL MARKET
FIGURE 37 US: NUMBER OF CASES OF SEXUALLY TRANSMITTED DISEASES, 2017 VS. 2021
TABLE 54 MARKET FOR GYNECOLOGY AND UROLOGY DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.14 PERSONAL CARE DEVICES
6.14.1 SHIFT IN CONSUMPTION PATTERN TOWARD PREMIUM PERSONAL CARE PRODUCTS TO FUEL MARKET
TABLE 55 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PERSONAL CARE DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.15 NEUROLOGY DEVICES
6.15.1 RISING GLOBAL BURDEN OF NEUROLOGICAL DISEASES TO DRIVE MARKET
TABLE 56 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR NEUROLOGY DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.16 PATIENT MONITORING DEVICES
6.16.1 GROWING AVAILABILITY OF INTEGRATED MONITORING TECHNOLOGY TO AID MARKET
TABLE 57 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PATIENT MONITORING DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.17 PATIENT ASSISTIVE DEVICES
6.17.1 RISING GERIATRIC POPULATION GLOBALLY TO PROPEL MARKET
TABLE 58 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PATIENT ASSISTIVE DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.18 OTHER DEVICES
TABLE 59 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR OTHER DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)

7 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE (Page No. - )
7.1 INTRODUCTION
TABLE 60 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2020-2027 (USD MILLION)
7.2 COMPARISON OF DEVICE CLASSIFICATION BY COUNTRY/REGION
7.2.1 US
7.2.1.1 Class I: General controls
7.2.1.2 Class II: General controls with special controls
7.2.1.3 Class III: General controls with special controls and premarket approval
7.2.2 CANADA
7.2.3 EUROPEAN UNION AND EUROPEAN FREE TRADE ASSOCIATION
7.2.3.1 Class I medical devices
7.2.3.1.1 Class Is: Non-invasive devices
7.2.3.1.2 Class Ir: Reusable surgical instruments
7.2.3.1.3 Class Im: Low-risk measuring devices
7.2.3.2 Class IIa medical devices
7.2.3.3 Class IIb medical devices
7.2.3.4 Class III medical devices
7.2.4 ASIA PACIFIC
7.2.4.1 China
7.2.4.2 India
7.2.4.3 Japan
7.2.4.4 Australia
7.3 CLASS II MEDICAL DEVICES
7.3.1 HIGH-VOLUME UTILIZATION OF CLASS II MEDICAL DEVICES BY END USERS TO SUPPORT MARKET
TABLE 61 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR CLASS II MEDICAL DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
7.4 CLASS I MEDICAL DEVICES
7.4.1 CLASS I MEDICAL DEVICES TO POSSESS MINIMUM POTENTIAL TO HARM USERS
TABLE 62 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR CLASS I MEDICAL DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
7.5 CLASS III MEDICAL DEVICES
7.5.1 CLASS III MEDICAL DEVICES TO INVOLVE HIGHEST LEVEL OF HEALTH RISKS
TABLE 63 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR CLASS III MEDICAL DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)

8 MARKET, BY SERVICE (Page No. - 160)
8.1 INTRODUCTION
FIGURE 38 STAGES INVOLVED IN CONTRACT MANUFACTURING OF MEDICAL DEVICES
TABLE 64 MARKET, BY SERVICE, 2020-2027 (USD MILLION)
8.2 DEVICE DEVELOPMENT AND MANUFACTURING SERVICES
TABLE 65 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 66 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY COUNTRY, 2020-2027 (USD MILLION)
8.2.1 DEVICE AND COMPONENT MANUFACTURING SERVICES
8.2.1.1 Device manufacturing services to be largest and fastest-growing segment
TABLE 67 DEVICE AND COMPONENT MANUFACTURING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
8.2.2 PROCESS DEVELOPMENT SERVICES
8.2.2.1 Transition from conventional contract manufacturing to automated contract manufacturing and testing to drive growth
FIGURE 39 DEVICE PROCESS DEVELOPMENT SERVICES
TABLE 68 PROCESS DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
8.2.3 DEVICE ENGINEERING SERVICES
8.2.3.1 Complexity of device engineering services to propel segment
TABLE 69 DEVICE ENGINEERING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
8.3 QUALITY MANAGEMENT SERVICES
TABLE 70 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 71 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY COUNTRY, 2020-2027 (USD MILLION)
8.3.1 PACKAGING VALIDATION SERVICES
8.3.1.1 Increasing product safety concerns for medical devices to aid market
TABLE 72 PACKAGING VALIDATION SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
8.3.2 INSPECTION AND TESTING SERVICES
8.3.2.1 Increased technological expertise in testing services to eliminate large capital and overhead investments
TABLE 73 INSPECTION AND TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
8.3.3 STERILIZATION SERVICES
8.3.3.1 Rising complexity of sterility standards to augment market
TABLE 74 MEDICAL DEVICE STERILIZATION PATENTS PUBLISHED BY MAJOR COMPANIES WORLDWIDE
TABLE 75 STERILIZATION SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
8.4 PACKAGING AND ASSEMBLY SERVICES
FIGURE 40 FINAL ASSEMBLY SERVICES IN GLOBAL VALUE CHAIN OF MEDICAL DEVICES
TABLE 76 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 77 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY COUNTRY, 2020-2027 (USD MILLION)
8.4.1 PRIMARY AND SECONDARY PACKAGING SERVICES
8.4.1.1 Growing concerns for patient safety to aid segment
TABLE 78 PRIMARY AND SECONDARY PACKAGING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
8.4.2 LABELING SERVICES
8.4.2.1 Export bans and product recalls due to improper labeling to support market
TABLE 79 LABELING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
8.4.3 OTHER PACKAGING AND ASSEMBLY SERVICES
TABLE 80 OTHER PACKAGING AND ASSEMBLY SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
8.5 OTHER SERVICES
TABLE 81 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR OTHER SERVICES, BY COUNTRY, 2020-2027 (USD MILLION)

9 MARKET, BY REGION (Page No. - 180)
9.1 INTRODUCTION
FIGURE 41 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
TABLE 82 MARKET, BY REGION, 2020-2027 (USD MILLION)
9.2 ASIA PACIFIC
9.2.1 IMPACT OF RECESSION
FIGURE 42 ASIA PACIFIC: MARKET SNAPSHOT
TABLE 83 ASIA PACIFIC: MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 84 ASIA PACIFIC: MARKET, BY DEVICE, 2020-2027 (USD MILLION)
TABLE 85 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 86 ASIA PACIFIC: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 87 ASIA PACIFIC: MARKET, BY CLASS OF DEVICE, 2020-2027 (USD MILLION)
TABLE 88 ASIA PACIFIC: MARKET, BY SERVICE, 2020-2027 (USD MILLION)
TABLE 89 ASIA PACIFIC: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 90 ASIA PACIFIC: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 91 ASIA PACIFIC: MARKET PACKAGING & ASSEMBLY SERVICES, BY TYPE, 2020-2027 (USD MILLION)
9.2.2 CHINA
9.2.2.1 Low labor costs and rapidly changing healthcare infrastructure to drive market
TABLE 92 CHINA: KEY MACROINDICATORS
TABLE 93 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020-2027 (USD MILLION)
TABLE 94 CHINA: MARKET FOR IVD DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 95 CHINA: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 96 CHINA: MARKET, BY CLASS OF DEVICE, 2020-2027 (USD MILLION)
TABLE 97 CHINA: MARKET, BY SERVICE, 2020-2027 (USD MILLION)
TABLE 98 CHINA: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 99 CHINA: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 100 CHINA: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020-2027 (USD MILLION)
9.2.3 JAPAN
9.2.3.1 Universal healthcare reimbursement policies to propel market
TABLE 101 JAPAN: KEY MACROINDICATORS
TABLE 102 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020-2027 (USD MILLION)
TABLE 103 JAPAN: MARKET FOR IVD DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 104 JAPAN: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 105 JAPAN: MARKET, BY CLASS OF DEVICE, 2020-2027 (USD MILLION)
TABLE 106 JAPAN: MARKET, BY SERVICE, 2020-2027 (USD MILLION)
TABLE 107 JAPAN: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 108 JAPAN: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 109 JAPAN: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020-2027 (USD MILLION)
9.2.4 MALAYSIA AND SINGAPORE
9.2.4.1 Increasing R&D activities and investments by established players to augment market
TABLE 110 MALAYSIA: KEY MACROINDICATORS
TABLE 111 SINGAPORE: KEY MACROINDICATORS
TABLE 112 MALAYSIA AND SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020-2027 (USD MILLION)
TABLE 113 MALAYSIA AND SINGAPORE: MARKET FOR IVD DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 114 MALAYSIA AND SINGAPORE: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 115 MALAYSIA AND SINGAPORE: MARKET, BY CLASS OF DEVICE, 2020-2027 (USD MILLION)
TABLE 116 MALAYSIA AND SINGAPORE: MARKET, BY SERVICE, 2020-2027 (USD MILLION)
TABLE 117 MALAYSIA AND SINGAPORE: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 118 MALAYSIA AND SINGAPORE: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 119 MALAYSIA AND SINGAPORE: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020-2027 (USD MILLION)
9.2.5 INDIA
9.2.5.1 Rising contract manufacturing capabilities to support market
TABLE 120 INDIA: KEY MACROINDICATORS
TABLE 121 INDIA: MARKET, BY DEVICE, 2020-2027 (USD MILLION)
TABLE 122 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 123 INDIA: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 124 INDIA: MARKET, BY CLASS OF DEVICE, 2020-2027 (USD MILLION)
TABLE 125 INDIA: MARKET, BY SERVICE, 2020-2027 (USD MILLION)
TABLE 126 INDIA: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 127 INDIA: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 128 INDIA: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020-2027 (USD MILLION)
9.2.6 AUSTRALIA AND NEW ZEALAND
9.2.6.1 Need for advanced medical and diagnostic tools to fuel market
TABLE 129 AUSTRALIA: KEY MACROINDICATORS
TABLE 130 NEW ZEALAND: KEY MACROINDICATORS
TABLE 131 AUSTRALIA AND NEW ZEALAND: MARKET, BY DEVICE, 2020-2027 (USD MILLION)
TABLE 132 AUSTRALIA AND NEW ZEALAND: MARKET FOR IVD DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 133 AUSTRALIA AND NEW ZEALAND: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 134 AUSTRALIA AND NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2020-2027 (USD MILLION)
TABLE 135 AUSTRALIA AND NEW ZEALAND: MARKET, BY SERVICE, 2020-2027 (USD MILLION)
TABLE 136 AUSTRALIA AND NEW ZEALAND: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 137 AUSTRALIA AND NEW ZEALAND: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 138 AUSTRALIA AND NEW ZEALAND: MARKET FOR PACKAGING AND ASSEMBLY SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
9.2.7 SOUTH KOREA
9.2.7.1 High-value imports from other countries to offer opportunities
TABLE 139 SOUTH KOREA: MEDICAL DEVICES MARKET (USD BILLION)
TABLE 140 SOUTH KOREA: KEY MACROINDICATORS
TABLE 141 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020-2027 (USD MILLION)
TABLE 142 SOUTH KOREA: MARKET FOR IVD DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 143 SOUTH KOREA: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 144 SOUTH KOREA: MARKET, BY CLASS OF DEVICE, 2020-2027 (USD MILLION)
TABLE 145 SOUTH KOREA: MARKET, BY SERVICE, 2020-2027 (USD MILLION)
TABLE 146 SOUTH KOREA: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 147 SOUTH KOREA: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 148 SOUTH KOREA: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020-2027 (USD MILLION)
9.2.8 REST OF ASIA PACIFIC
TABLE 149 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020-2027 (USD MILLION)
TABLE 150 REST OF ASIA PACIFIC: MARKET FOR IVD DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 151 REST OF ASIA PACIFIC: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 152 REST OF ASIA PACIFIC: MARKET, BY CLASS OF DEVICE, 2020-2027 (USD MILLION)
TABLE 153 REST OF ASIA PACIFIC: MARKET, BY SERVICE, 2020-2027 (USD MILLION)
TABLE 154 REST OF ASIA PACIFIC: DEVICE DEVELOPMENT & MANUFACTURING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 155 REST OF ASIA PACIFIC: QUALITY MANAGEMENT SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 156 REST OF ASIA PACIFIC: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020-2027 (USD MILLION)
9.3 NORTH AMERICA
9.3.1 IMPACT OF RECESSION
TABLE 157 NORTH AMERICA: MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 158 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020-2027 (USD MILLION)
TABLE 159 NORTH AMERICA: MARKET FOR IVD DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 160 NORTH AMERICA: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 161 NORTH AMERICA: MARKET, BY CLASS OF DEVICE, 2020-2027 (USD MILLION)
TABLE 162 NORTH AMERICA: MARKET, BY SERVICE, 2020-2027 (USD MILLION)
TABLE 163 NORTH AMERICA: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 164 NORTH AMERICA: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 165 NORTH AMERICA: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020-2027 (USD MILLION)
9.3.2 US
9.3.2.1 Increasing in-house manufacturing costs to encourage medical device companies toward contract manufacturing
TABLE 166 US: KEY MACROINDICATORS
TABLE 167 US: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020-2027 (USD MILLION)
TABLE 168 US: MARKET FOR IVD DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 169 US: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 170 US: MARKET, BY CLASS OF DEVICE, 2020-2027 (USD MILLION)
TABLE 171 US: MARKET, BY SERVICE, 2020-2027 (USD MILLION)
TABLE 172 US: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 173 US: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 174 US: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020-2027 (USD MILLION)
9.3.3 CANADA
9.3.3.1 Strong presence of key contract manufacturing companies to augment market
TABLE 175 CANADA: KEY MACROINDICATORS
TABLE 176 CANADA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020-2027 (USD MILLION)
TABLE 177 CANADA: MARKET FOR IVD DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 178 CANADA: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 179 CANADA: MARKET, BY CLASS OF DEVICE, 2020-2027 (USD MILLION)
TABLE 180 CANADA: MARKET, BY SERVICE, 2020-2027 (USD MILLION)
TABLE 181 CANADA: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 182 CANADA: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 183 CANADA: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020-2027 (USD MILLION)
9.4 EUROPE
9.4.1 IMPACT OF RECESSION
TABLE 184 EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 185 EUROPE: MARKET, BY DEVICE, 2020-2027 (USD MILLION)
TABLE 186 EUROPE: MARKET FOR IVD DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 187 EUROPE: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 188 EUROPE: MARKET, BY CLASS OF DEVICE, 2020-2027 (USD MILLION)
TABLE 189 EUROPE: MARKET, BY SERVICE, 2020-2027 (USD MILLION)
TABLE 190 EUROPE: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 191 EUROPE: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 192 EUROPE: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020-2027 (USD MILLION)
9.4.2 GERMANY
9.4.2.1 Germany to hold largest market share due to presence of major device manufacturers and high healthcare expenditure
TABLE 193 GERMANY: KEY MACROINDICATORS
TABLE 194 GERMANY: MARKET, BY DEVICE, 2020-2027 (USD MILLION)
TABLE 195 GERMANY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 196 GERMANY: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 197 GERMANY: MARKET, BY CLASS OF DEVICE, 2020-2027 (USD MILLION)
TABLE 198 GERMANY: MARKET, BY SERVICE, 2020-2027 (USD MILLION)
TABLE 199 GERMANY: MARKET FOR DEVICE DEVELOPMENT & MANUFACTURING SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 200 GERMANY: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 201 GERMANY: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020-2027 (USD MILLION)
9.4.3 FRANCE
9.4.3.1 Increasing government pressure for healthcare cost reduction and budgetary constraints to support market
TABLE 202 FRANCE: KEY MACROINDICATORS
TABLE 203 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020-2027 (USD MILLION)
TABLE 204 FRANCE: MARKET FOR IVD DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 205 FRANCE: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 206 FRANCE: MARKET, BY CLASS OF DEVICE, 2020-2027 (USD MILLION)
TABLE 207 FRANCE: MARKET, BY SERVICE, 2020-2027 (USD MILLION)
TABLE 208 FRANCE: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 209 FRANCE: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 210 FRANCE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020-2027 (USD MILLION)
9.4.4 UK
9.4.4.1 Rising number of accredited clinical and hospital laboratories to propel market
TABLE 211 UK: KEY MACROINDICATORS
TABLE 212 UK: MARKET, BY DEVICE, 2020-2027 (USD MILLION)
TABLE 213 UK: MARKET FOR IVD DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 214 UK: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 215 UK: MARKET, BY CLASS OF DEVICE, 2020-2027 (USD MILLION)
TABLE 216 UK: MARKET, BY SERVICE, 2020-2027 (USD MILLION)
TABLE 217 UK: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 218 UK: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 219 UK: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020-2027 (USD MILLION)
9.4.5 ITALY
9.4.5.1 Healthcare coverage for all citizens and foreign residents to increase demand for medical devices
TABLE 220 ITALY: KEY MACROINDICATORS
TABLE 221 ITALY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020-2027 (USD MILLION)
TABLE 222 ITALY: MARKET FOR IVD DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 223 ITALY: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 224 ITALY: MARKET, BY CLASS OF DEVICE, 2020-2027 (USD MILLION)
TABLE 225 ITALY: MARKET, BY SERVICE, 2020-2027 (USD MILLION)
TABLE 226 ITALY: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 227 ITALY: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 228 ITALY: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020-2027 (USD MILLION)
9.4.6 SPAIN
9.4.6.1 Increasing adoption of home-based medical devices to drive market
TABLE 229 SPAIN: KEY MACROINDICATORS
TABLE 230 SPAIN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020-2027 (USD MILLION)
TABLE 231 SPAIN: MARKET FOR IVD DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 232 SPAIN: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 233 SPAIN: MARKET, BY CLASS OF DEVICE, 2020-2027 (USD MILLION)
TABLE 234 SPAIN: MARKET, BY SERVICE, 2020-2027 (USD MILLION)
TABLE 235 SPAIN: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 236 SPAIN: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 237 SPAIN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
9.4.7 REST OF EUROPE
TABLE 238 REST OF EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020-2027 (USD MILLION)
TABLE 239 REST OF EUROPE: MARKET FOR IVD DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 240 REST OF EUROPE: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 241 REST OF EUROPE: MARKET, BY CLASS OF DEVICE, 2020-2027 (USD MILLION)
TABLE 242 REST OF EUROPE: MARKET, BY SERVICE, 2020-2027 (USD MILLION)
TABLE 243 REST OF EUROPE: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 244 REST OF EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 245 REST OF EUROPE: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020-2027 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 IMPACT OF RECESSION
TABLE 246 LATIN AMERICA: MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 247 LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020-2027 (USD MILLION)
TABLE 248 LATIN AMERICA: MARKET FOR IVD DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 249 LATIN AMERICA: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 250 LATIN AMERICA: MARKET, BY CLASS OF DEVICE, 2020-2027 (USD MILLION)
TABLE 251 LATIN AMERICA: MARKET, BY SERVICE, 2020-2027 (USD MILLION)
TABLE 252 LATIN AMERICA: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 253 LATIN AMERICA: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 254 LATIN AMERICA: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020-2027 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Mexico to be largest segment of Latin American MARKET
TABLE 255 MEXICO: KEY MACROINDICATORS
TABLE 256 MEXICO: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020-2027 (USD MILLION)
TABLE 257 MEXICO: MARKET FOR IVD DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 258 MEXICO: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 259 MEXICO: MARKET, BY CLASS OF DEVICE, 2020-2027 (USD MILLION)
TABLE 260 MEXICO: MARKET, BY SERVICE, 2020-2027 (USD MILLION)
TABLE 261 MEXICO: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 262 MEXICO: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 263 MEXICO: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020-2027 (USD MILLION)
9.5.3 BRAZIL
9.5.3.1 Favorable government initiatives and willingness to pay for better healthcare to boost market
TABLE 264 BRAZIL: KEY MACROINDICATORS
TABLE 265 BRAZIL: MARKET, BY DEVICE, 2020-2027 (USD MILLION)
TABLE 266 BRAZIL: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 267 BRAZIL: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 268 BRAZIL: MARKET, BY CLASS OF DEVICE, 2020-2027 (USD MILLION)
TABLE 269 BRAZIL: MARKET, BY SERVICE, 2020-2027 (USD MILLION)
TABLE 270 BRAZIL: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 271 BRAZIL: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 272 BRAZIL: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020-2027 (USD MILLION)
9.5.4 REST OF LATIN AMERICA
TABLE 273 REST OF LATIN AMERICA: MARKET, BY DEVICE, 2020-2027 (USD MILLION)
TABLE 274 REST OF LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 275 REST OF LATIN AMERICA: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 276 REST OF LATIN AMERICA: MARKET, BY CLASS OF DEVICE, 2020-2027 (USD MILLION)
TABLE 277 REST OF LATIN AMERICA: MARKET, BY SERVICE, 2020-2027 (USD MILLION)
TABLE 278 REST OF LATIN AMERICA: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 279 REST OF LATIN AMERICA: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 280 REST OF LATIN AMERICA: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020-2027 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 IMPACT OF RECESSION
9.6.2 GROWING HEALTHCARE INVESTMENTS AND IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
TABLE 281 MIDDLE EAST & AFRICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020-2027 (USD MILLION)
TABLE 282 MIDDLE EAST & AFRICA: MARKET FOR IVD DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 283 MIDDLE EAST & AFRICA: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 284 MIDDLE EAST & AFRICA: MARKET, BY CLASS OF DEVICE, 2020-2027 (USD MILLION)
TABLE 285 MIDDLE EAST & AFRICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD MILLION)
TABLE 286 MIDDLE EAST & AFRICA: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 287 MIDDLE EAST & AFRICA: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 288 MIDDLE EAST & AFRICA: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020-2027 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 296)
10.1 OVERVIEW
10.2 KEY STRATEGIES ADOPTED BY PLAYERS
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 43 TOP MARKET PLAYERS DOMINATE MARKET
10.4 MARKET SHARE (2021)
TABLE 289 MARKET: DEGREE OF COMPETITION
10.5 MARKET SHARE ANALYSIS
FIGURE 44 MARKET SHARE, BY KEY PLAYER, 2021
10.6 COMPANY EVALUATION QUADRANT
10.6.1 STARS
10.6.2 EMERGING LEADERS
10.6.3 PERVASIVE PLAYERS
10.6.4 PARTICIPANTS
FIGURE 45 MARKET: COMPANY EVALUATION QUADRANT (2021)
10.7 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2021)
10.7.1 PROGRESSIVE COMPANIES
10.7.2 DYNAMIC COMPANIES
10.7.3 STARTING BLOCKS
10.7.4 RESPONSIVE COMPANIES
FIGURE 46 MARKET: SMES/START-UPS COMPANY EVALUATION QUADRANTS, 2021
10.8 COMPETITIVE BENCHMARKING
10.8.1 COMPANY FOOTPRINT FOR KEY PLAYERS
10.8.2 DEVICE: COMPANY FOOTPRINT (1/2)
10.8.3 DEVICE: COMPANY FOOTPRINT (2/2)
10.8.4 CLASS OF DEVICE: COMPANY FOOTPRINT
10.8.5 SERVICE: COMPANY FOOTPRINT
10.9 REGION: COMPANY FOOTPRINT
10.10 MARKET: R&D EXPENDITURE
FIGURE 47 R&D EXPENDITURE OF KEY PLAYERS IN MARKET (2020/2021)
10.11 COMPETITIVE SCENARIO
10.11.1 PRODUCT LAUNCHES
TABLE 290 PRODUCT LAUNCHES (JANUARY 2019- NOVEMBER 2022)
10.11.2 DEALS
TABLE 291 DEALS (JANUARY 2019-NOVEMBER 2022)
10.11.3 OTHER DEVELOPMENTS
TABLE 292 OTHER DEVELOPMENTS (JANUARY 2019-NOVEMBER 2022)

11 COMPANY PROFILES (Page No. - 315)
11.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1 JABIL INC.
TABLE 293 JABIL INC.: COMPANY OVERVIEW
FIGURE 48 JABIL INC.: COMPANY SNAPSHOT (2022)
11.1.2 FLEX LTD.
TABLE 294 FLEX LTD.: COMPANY OVERVIEW
FIGURE 49 FLEX LTD.: COMPANY SNAPSHOT (2022)
11.1.3 PLEXUS CORP.
TABLE 295 PLEXUS CORP.: COMPANY OVERVIEW
FIGURE 50 PLEXUS CORP.: COMPANY SNAPSHOT (2021)
11.1.4 SANMINA CORPORATION
TABLE 296 SANMINA CORPORATION: COMPANY OVERVIEW
FIGURE 51 SANMINA CORPORATION: COMPANY SNAPSHOT (2021)
11.1.5 INTEGER HOLDINGS CORPORATION
TABLE 297 INTEGER HOLDINGS CORPORATION: COMPANY OVERVIEW
FIGURE 52 INTEGER HOLDINGS CORPORATION: COMPANY SNAPSHOT (2021)
11.1.6 TE CONNECTIVITY LTD.
TABLE 298 TE CONNECTIVITY LTD.: COMPANY OVERVIEW
FIGURE 53 TE CONNECTIVITY LTD.: COMPANY SNAPSHOT (2021)
11.1.7 NIPRO CORPORATION
TABLE 299 NIPRO CORPORATION: COMPANY OVERVIEW
FIGURE 54 NIPRO CORPORATION: COMPANY SNAPSHOT (2022)
11.1.8 CELESTICA INC.
TABLE 300 CELESTICA INC.: COMPANY OVERVIEW
FIGURE 55 CELESTICA INC.: COMPANY SNAPSHOT (2021)
11.1.9 WEST PHARMACEUTICAL SERVICES, INC.
TABLE 301 WEST PHARMACEUTICALS SERVICES, INC.: COMPANY OVERVIEW
FIGURE 56 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT (2021)
11.1.10 BENCHMARK ELECTRONICS INC.
TABLE 302 BENCHMARK ELECTRONICS INC.: COMPANY OVERVIEW
FIGURE 57 BENCHMARK ELECTRONICS INC.: COMPANY SNAPSHOT (2021)
11.1.11 RECIPHARM AB
TABLE 303 RECIPHARM AB: COMPANY OVERVIEW
11.1.12 GERRESHEIMER AG
TABLE 304 GERRESHEIMER AG.: COMPANY OVERVIEW
FIGURE 58 GERRESHEIMER AG: COMPANY SNAPSHOT (2021)
11.1.13 KIMBALL ELECTRONICS, INC.
TABLE 305 KIMBALL ELECTRONICS, INC.: COMPANY OVERVIEW
FIGURE 59 KIMBALL ELECTRONICS, INC.: COMPANY SNAPSHOT (2022)
11.2 OTHER PLAYERS
11.2.1 NORTECH SYSTEMS INCORPORATED
TABLE 306 NORTECH SYSTEMS INCORPORATED: COMPANY OVERVIEW
FIGURE 60 NORTECH SYSTEM INCORPORATED: COMPANY SNAPSHOT (2021)
11.2.2 NEMERA
TABLE 307 NEMERA: COMPANY OVERVIEW
11.2.3 VIANT MEDICAL HOLDINGS, INC.
TABLE 308 VIANT MEDICAL HOLDINGS, INC.: COMPANY OVERVIEW
11.2.4 TECOMET, INC.
TABLE 309 TECOMET INC.: COMPANY OVERVIEW
11.2.5 SMC LTD.
TABLE 310 SMC LTD.: COMPANY OVERVIEW
11.2.6 PHILLIPS-MEDISIZE CORPORATION
TABLE 311 PHILLIPS-MEDISIZE CORPORATION: COMPANY OVERVIEW
11.2.7 TESSY PLASTICS CORP.
TABLE 312 TESSY PLASTICS CORP.: COMPANY OVERVIEW
11.2.8 CARCLO PLC
TABLE 313 CARCLO PLC: COMPANY OVERVIEW
FIGURE 61 CARCLO PLC: COMPANY SNAPSHOT (2021)
11.2.9 NOLATO GW, INC. (A PART OF NOLATO AB)
TABLE 314 NOLATO GW, INC.: COMPANY OVERVIEW
FIGURE 62 NOLATO GW, INC.: COMPANY SNAPSHOT (2021)
11.2.10 MEHOW
TABLE 315 MEHOW: COMPANY OVERVIEW
11.2.11 TEKNI-PLEX
TABLE 316 TEKNI-PLEX: COMPANY OVERVIEW
11.2.12 PETER’S TECHNOLOGY
TABLE 317 PETER’S TECHNOLOGY: COMPANY OVERVIEW
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.

12 APPENDIX (Page No. - 405)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS 317 62
TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 45)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 MARKET SEGMENTATION
FIGURE 2 MARKET: REGIONAL SEGMENTATION
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 51)
2.1 RESEARCH DATA
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 4 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 8 SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: FLEX, LTD.
FIGURE 10 SUPPLY SIDE ANALYSIS: MARKET (2021)
FIGURE 11 DEMAND SIDE ESTIMATION FOR MARKET
FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022-2027)
FIGURE 13 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
2.2.1 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 14 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 STUDY ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.6.2 SCOPE-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: MARKET
2.8 IMPACT OF RECESSION ON MEDICAL DEVICE CONTRACT MANUFACTURING MARKET

3 EXECUTIVE SUMMARY (Page No. - 67)
FIGURE 15 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2022 VS. 2027 (USD MILLION)
FIGURE 16 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2022 VS. 2027 (USD MILLION)
FIGURE 17 MARKET, BY SERVICE, 2022 VS. 2027 (USD MILLION)
FIGURE 18 GEOGRAPHICAL SNAPSHOT OF MEDICAL DEVICE CONTRACT MANUFACTURING MARKET

4 PREMIUM INSIGHTS (Page No. - 70)
4.1 MARKET OVERVIEW
FIGURE 19 TECHNOLOGICAL ADVANCEMENTS IN MEDICAL DEVICE MODALITIES TO DRIVE MARKET
4.2 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 20 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.3 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.4 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: REGIONAL MIX
FIGURE 22 ASIA PACIFIC TO DOMINATE MARKET IN 2027

5 MARKET OVERVIEW (Page No. - 72)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 23 MARKET DYNAMICS: MARKET
TABLE 3 MARKET DYNAMICS: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Growth in medical devices market in developing countries
FIGURE 24 GDP GROWTH FORECAST: COMPARISON AMONG INDIA, CHINA, US, AND GERMANY, 2020 VS. 2040 (FORECAST)
5.2.1.2 Adoption of robotics and automation in manufacturing processes
5.2.1.3 Technological advancements in medical device modalities
FIGURE 25 FACTORS DRIVING DEMAND FOR CONTRACT MANUFACTURING
5.2.1.4 Impact of industry 4.0 on medical device industry
TABLE 4 DEFINITIONS OF CRITICAL ELEMENTS IN INDUSTRY 4.0 SYSTEM
5.2.2 RESTRAINTS
5.2.2.1 Consolidation in medical devices market by acquiring small and medium-sized companies
TABLE 5 KEY ACQUISITIONS IN MEDICAL DEVICE INDUSTRY (2019-2022)
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing healthcare expenditure, infrastructure, and awareness in developing countries
TABLE 6 HEALTHCARE EXPENDITURE (%), BY COUNTRY (2010 TO 2021)
FIGURE 26 ASIA PACIFIC: HEALTHCARE EXPENDITURE PER CAPITA (USD) (2002 TO 2019)
5.2.3.2 Rising geriatric population and its associated diseases
TABLE 7 ESTIMATED INCREASE IN GERIATRIC POPULATION, BY REGION, 2019 VS. 2050
TABLE 8 AVERAGE LIFE EXPECTANCY, 2023 (FORECAST)
5.2.4 CHALLENGES
5.2.4.1 Lack of constant innovation to balance technological capabilities against costs
5.3 PORTER’S FIVE FORCES ANALYSIS
FIGURE 27 PORTER’S FIVE FORCES ANALYSIS (2020): MEDICAL DEVICE CONTRACT MANUFACTURING MARKET
TABLE 9 MARKET: PORTER’S FIVE FORCES ANALYSIS
5.3.1 THREAT OF NEW ENTRANTS
5.3.1.1 Growth in overall medical device industry
5.3.1.2 Demand for compact, cost-effective, and non-invasive devices
5.3.1.3 Consolidation
5.3.1.4 Poor financing environment
5.3.1.5 Stringent regulatory environment
5.3.2 THREAT OF SUBSTITUTES
5.3.2.1 Undesirability of existing portfolios
5.3.2.2 Combination and integration of multiple technologies
5.3.2.3 Availability of alternatives
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.3.1 Big medical device contract manufacturing companies
5.3.3.2 Institutional technology providers
5.3.3.3 Innovative technologies
5.3.3.4 Dysfunctional companies
5.3.3.5 Academic inventors
5.3.4 BARGAINING POWER OF BUYERS
5.3.4.1 Few buyers and many sellers
5.3.4.2 Buy out threat
5.3.4.3 Demand for new pipeline services
5.3.4.4 Point of differentiation
5.3.5 INTENSITY OF COMPETITIVE RIVALRY
5.3.5.1 Similar spectrum of services offered
5.3.5.2 Similar funding source
5.3.5.3 Self-funded big contract manufacturers
5.3.5.4 Highly fragmented industry
5.4 TARIFF AND REGULATORY LANDSCAPE
5.4.1 REGULATORY ANALYSIS
5.4.1.1 North America
5.4.1.1.1 US
TABLE 10 US: CLASSIFICATION OF MEDICAL EQUIPMENT
TABLE 11 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.1.1.2 Canada
TABLE 12 CANADA: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.1.2 Europe
TABLE 13 EUROPE: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.1.3 Asia Pacific
5.4.1.3.1 Japan
TABLE 14 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.1.3.2 China
TABLE 15 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.1.3.3 India
5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.5 KEY CONFERENCES AND EVENTS IN 2022-2023
TABLE 21 DETAILED LIST OF CONFERENCES AND EVENTS
5.6 PATENT ANALYSIS
5.6.1 PATENT PUBLICATION TRENDS FOR MEDICAL DEVICES
FIGURE 28 PATENT PUBLICATION TRENDS (JANUARY 2012-NOVEMBER 2022)
5.6.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 29 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR MEDICAL DEVICES PATENTS (JANUARY 2012-NOVEMBER 2022)
FIGURE 30 TOP 10 APPLICANT COUNTRIES/REGIONS FOR MEDICAL DEVICES PATENTS (JANUARY 2012-NOVEMBER 2022)
TABLE 22 MEDICAL DEVICES: LIST OF MAJOR PATENTS
5.7 TECHNOLOGY ANALYSIS
5.7.1 KEY TECHNOLOGIES
5.7.1.1 Digital Transformation
5.7.1.2 Robotics and Automation
5.7.2 ADJACENT TECHNOLOGIES
5.7.2.1 Artificial Intelligence
5.7.2.2 Big Data
5.7.3 COMPLEMENTARY TECHNOLOGIES
5.7.3.1 5G
5.8 SUPPLY CHAIN ANALYSIS
FIGURE 31 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: SUPPLY CHAIN (2020)
5.9 ECOSYSTEM ANALYSIS
FIGURE 32 MARKET: ECOSYSTEM ANALYSIS (2020)
5.10 TRADE ANALYSIS
TABLE 23 IMPORT VALUE OF MEDICAL DEVICES FOR TOP 10 COUNTRIES IN 2021
TABLE 24 EXPORT VALUE OF MEDICAL DEVICES FOR TOP 10 COUNTRIES IN 2021
5.11 YC-YCC ANALYSIS
FIGURE 33 YC-YCC SHIFT IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL DEVICES
TABLE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL DEVICES
5.12.2 BUYING CRITERIA
FIGURE 35 KEY BUYING CRITERIA FOR MEDICAL DEVICES
TABLE 26 KEY BUYING CRITERIA FOR MEDICAL DEVICES
5.13 ADJACENT MARKETS FOR MEDICAL DEVICE CONTRACT MANUFACTURING
FIGURE 36 ADJACENT MARKETS FOR MEDICAL DEVICE CONTRACT MANUFACTURING
5.14 INDUSTRY TRENDS
5.14.1 INCREASING CONSOLIDATION OF ORIGINAL EQUIPMENT MANUFACTURERS AND CONTRACT MANUFACTURING ORGANIZATIONS
TABLE 27 KEY EXAMPLES OF OEM CONSOLIDATION IN LAST 5 YEARS
TABLE 28 KEY EXAMPLES OF CMO CONSOLIDATION
5.14.2 GROWING INTEREST OF PRIVATE EQUITY FIRMS IN MEDICAL DEVICE CONTRACT MANUFACTURING
TABLE 29 KEY INVESTMENTS BY PRIVATE EQUITY FIRMS
5.14.3 OUTSOURCING OF MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES
TABLE 30 EXAMPLES OF KEY COLLABORATIONS AND AGREEMENTS
5.14.4 INDUSTRY 5.0
5.15 IMPACT OF RECESSION ON MARKET

6 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE (Page No. - 110)
6.1 INTRODUCTION
TABLE 31 MARKET, BY DEVICE, 2020-2027 (USD MILLION)
6.2 IVD DEVICES
TABLE 32 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 33 MARKET FOR IVD DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.2.1 IVD CONSUMABLES
6.2.1.1 Increasing demand for reagents & kits and focus on COVID-19 screening to drive market
TABLE 34 IVD CONSUMABLES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.2.2 IVD EQUIPMENT
6.2.2.1 Advances in life sciences research to support market
TABLE 35 IVD EQUIPMENT MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.3 DIAGNOSTIC IMAGING DEVICES
6.3.1 ADOPTION OF NEW AND ADVANCED DIAGNOSTIC IMAGING SYSTEMS IN DEVELOPING COUNTRIES TO AUGMENT MARKET
TABLE 36 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DIAGNOSTIC IMAGING DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.4 CARDIOVASCULAR DEVICES
6.4.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO PROPEL MARKET
TABLE 37 PREVALENCE OF CARDIOVASCULAR DISEASES, 2015-2035
TABLE 38 MARKET FOR CARDIOVASCULAR DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.5 DRUG DELIVERY DEVICES
TABLE 39 MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020-2027 (USD MILLION)
TABLE 40 MARKET FOR DRUG DELIVERY DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.5.1 INFUSION DEVICES AND ADMINISTRATION SETS
6.5.1.1 Rising incidence of chronic diseases and number of surgical procedures to fuel market
TABLE 41 INFUSION DEVICES AND ADMINISTRATION SETS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.5.2 SYRINGES
6.5.2.1 High cost of safety syringes and increasing incidence of needlestick injuries to hinder market
TABLE 42 SYRINGES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.5.3 INHALERS
6.5.3.1 High prevalence of asthma, COPD, and cystic fibrosis to aid market
TABLE 43 INHALERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.5.4 AUTOINJECTORS AND PEN INJECTORS
6.5.4.1 Rising number of regulatory approvals for new drug therapies and advancements to support market
TABLE 44 RECENT APPROVALS FOR AUTOINJECTORS AND PEN INJECTORS GLOBALLY (2019-2022)
TABLE 45 AUTOINJECTORS AND PEN INJECTORS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.6 ORTHOPEDIC DEVICES
6.6.1 HIGH PREVALENCE OF ORTHOPEDIC CONDITIONS TO DRIVE MARKET
TABLE 46 MARKET FOR ORTHOPEDIC DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.7 RESPIRATORY CARE DEVICES
6.7.1 COVID-19 TO BOOST DEMAND FOR CONTRACT MANUFACTURING OF RESPIRATORY CARE DEVICES
TABLE 47 MARKET FOR RESPIRATORY CARE DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.8 OPHTHALMOLOGY DEVICES
6.8.1 INCREASING PREVALENCE OF OPHTHALMIC DISEASES TO DRIVE MARKET
TABLE 48 MARKET FOR OPHTHALMOLOGY DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.9 SURGICAL DEVICES
6.9.1 INCREASE IN SURGICAL PROCEDURES TO FUEL MARKET
TABLE 49 MARKET FOR SURGICAL DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.10 DIABETES CARE DEVICES
6.10.1 RISING PREVALENCE OF DIABETES TO PROPEL MARKET
TABLE 50 TOP FIVE COUNTRIES WITH HIGHEST NUMBER OF DIABETICS (20-79 YEARS) (2021 VS. 2045)
TABLE 51 MARKET FOR DIABETES CARE DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.11 DENTAL DEVICES
6.11.1 RISING INCIDENCE OF DENTAL DISEASES TO DRIVE MARKET
TABLE 52 MARKET FOR DENTAL DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.12 ENDOSCOPY AND LAPAROSCOPY DEVICES
6.12.1 RISING PATIENT PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO AUGMENT MARKET
TABLE 53 MARKET FOR ENDOSCOPY AND LAPAROSCOPY DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.13 GYNECOLOGY AND UROLOGY DEVICES
6.13.1 GROWING AWARENESS AND PREVENTIVE CHECK-UPS FOR LATE-PHASE DIAGNOSIS OF STDS TO PROPEL MARKET
FIGURE 37 US: NUMBER OF CASES OF SEXUALLY TRANSMITTED DISEASES, 2017 VS. 2021
TABLE 54 MARKET FOR GYNECOLOGY AND UROLOGY DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.14 PERSONAL CARE DEVICES
6.14.1 SHIFT IN CONSUMPTION PATTERN TOWARD PREMIUM PERSONAL CARE PRODUCTS TO FUEL MARKET
TABLE 55 MARKET FOR PERSONAL CARE DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.15 NEUROLOGY DEVICES
6.15.1 RISING GLOBAL BURDEN OF NEUROLOGICAL DISEASES TO DRIVE MARKET
TABLE 56 MARKET FOR NEUROLOGY DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.16 PATIENT MONITORING DEVICES
6.16.1 GROWING AVAILABILITY OF INTEGRATED MONITORING TECHNOLOGY TO AID MARKET
TABLE 57 MARKET FOR PATIENT MONITORING DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.17 PATIENT ASSISTIVE DEVICES
6.17.1 RISING GERIATRIC POPULATION GLOBALLY TO PROPEL MARKET
TABLE 58 MARKET FOR PATIENT ASSISTIVE DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
6.18 OTHER DEVICES
TABLE 59 MARKET FOR OTHER DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)

7 MARKET, BY CLASS OF DEVICE (Page No. - )
7.1 INTRODUCTION
TABLE 60 MARKET, BY CLASS OF DEVICE, 2020-2027 (USD MILLION)
7.2 COMPARISON OF DEVICE CLASSIFICATION BY COUNTRY/REGION
7.2.1 US
7.2.1.1 Class I: General controls
7.2.1.2 Class II: General controls with special controls
7.2.1.3 Class III: General controls with special controls and premarket approval
7.2.2 CANADA
7.2.3 EUROPEAN UNION AND EUROPEAN FREE TRADE ASSOCIATION
7.2.3.1 Class I medical devices
7.2.3.1.1 Class Is: Non-invasive devices
7.2.3.1.2 Class Ir: Reusable surgical instruments
7.2.3.1.3 Class Im: Low-risk measuring devices
7.2.3.2 Class IIa medical devices
7.2.3.3 Class IIb medical devices
7.2.3.4 Class III medical devices
7.2.4 ASIA PACIFIC
7.2.4.1 China
7.2.4.2 India
7.2.4.3 Japan
7.2.4.4 Australia
7.3 CLASS II MEDICAL DEVICES
7.3.1 HIGH-VOLUME UTILIZATION OF CLASS II MEDICAL DEVICES BY END USERS TO SUPPORT MARKET
TABLE 61 MARKET FOR CLASS II MEDICAL DEVICES, BY COUNTRY, 2020-2027 (USD MILLION)
7.4 CLASS I MEDICAL DEVICE